HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michel C Nussenzweig Selected Research
Michel C Nussenzweig Research Topics
Disease
90
Infections
04/2022 - 01/2002
30
COVID-19
02/2022 - 01/2020
11
Viremia
01/2021 - 10/2013
9
Neoplasms (Cancer)
01/2017 - 01/2007
8
Lymphoma (Lymphomas)
01/2017 - 01/2007
5
Genetic Translocation (Chromosomal Translocation)
01/2017 - 10/2007
5
Malaria
02/2016 - 12/2002
5
Genomic Instability
06/2013 - 05/2002
5
Ataxia Telangiectasia (Louis Bar Syndrome)
02/2013 - 11/2004
5
B-Cell Lymphoma (Lymphoma, B Cell)
01/2013 - 09/2007
4
Reinfection
01/2022 - 01/2020
3
HIV Infections (HIV Infection)
04/2022 - 12/2020
3
Vesicular Stomatitis
12/2021 - 01/2021
3
Severe Acute Respiratory Syndrome
06/2021 - 12/2020
3
Pneumonia (Pneumonitis)
01/2021 - 10/2020
3
Autoimmune Diseases (Autoimmune Disease)
10/2020 - 01/2004
3
Inflammation (Inflammations)
04/2016 - 01/2002
3
Acquired Immunodeficiency Syndrome (AIDS)
04/2015 - 06/2013
3
Plasmacytoma
07/2012 - 08/2004
3
Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2008 - 03/2005
2
Breakthrough Infections
07/2022 - 10/2021
2
Burkitt Lymphoma (Burkitt's Lymphoma)
07/2012 - 08/2004
2
Nijmegen Breakage Syndrome
01/2007 - 12/2001
1
Convalescence
10/2021
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1
Omsk Hemorrhagic Fever (Fever, Omsk Hemorrhagic)
01/2021
1
Kyasanur Forest Disease
01/2021
1
Louping Ill
01/2021
1
Asymptomatic Infections
01/2021
1
Chronic Hepatitis B
12/2020
1
Emerging Communicable Diseases (Emerging Infectious Diseases)
10/2020
1
Zika Virus Infection
01/2020
1
Microcephaly
10/2019
1
Leukemia
01/2017
1
Lentivirus Infections
01/2017
1
Persistent Infection
01/2017
1
Hepatitis A (Hepatitis, Infectious)
05/2016
1
Experimental Melanoma
06/2014
1
Diphtheria
02/2014
Drug/Important Bio-Agent (IBA)
59
Antibodies
IBA
04/2022 - 01/2004
34
Broadly Neutralizing Antibodies
IBA
04/2022 - 12/2012
23
Vaccines
IBA
07/2022 - 10/2010
22
Neutralizing Antibodies
IBA
07/2022 - 09/2012
13
Monoclonal Antibodies
IBA
04/2021 - 09/2014
13
DNA (Deoxyribonucleic Acid)
IBA
01/2017 - 12/2001
10
Antigens
IBA
10/2021 - 01/2003
9
Epitopes
IBA
01/2022 - 04/2009
9
Cytidine Deaminase
IBA
12/2014 - 11/2009
8
Immunoglobulins (Immunoglobulin)
IBA
01/2020 - 08/2004
6
Proteins (Proteins, Gene)
FDA Link
01/2020 - 12/2001
5
mRNA Vaccines
IBA
02/2022 - 06/2021
5
Autoantibodies
IBA
01/2022 - 03/2005
5
Antiviral Agents (Antivirals)
IBA
04/2021 - 06/2020
5
Glycoproteins (Glycoprotein)
IBA
06/2016 - 06/2004
5
Histones (Histone)
IBA
11/2008 - 12/2001
4
Messenger RNA (mRNA)
IBA
07/2022 - 01/2021
4
chenodeoxycholate sulfate conjugate (CDCS)
IBA
04/2016 - 06/2012
3
Immunoglobulin G (IgG)
IBA
01/2021 - 07/2008
3
Antigen Receptors (Antigen Receptor)
IBA
10/2007 - 01/2007
2
BNT162 Vaccine
IBA
12/2021 - 10/2021
2
remdesivir
IBA
04/2021 - 01/2021
2
Single-Domain Antibodies
IBA
03/2021 - 01/2021
2
Cytokines
IBA
01/2021 - 05/2007
2
Explosive Agents (Explosives)
IBA
11/2020 - 06/2020
2
Interferons
IBA
10/2020 - 05/2007
2
Polysaccharides (Glycans)
IBA
01/2019 - 02/2017
2
Pharmaceutical Preparations
IBA
11/2018 - 04/2015
2
Autoantigens
IBA
09/2010 - 01/2002
2
1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
IBA
11/2009 - 12/2001
2
Phosphotransferases (Kinase)
IBA
11/2008 - 11/2004
2
Mannose Receptor
IBA
11/2003 - 01/2003
1
2019-nCoV Vaccine mRNA-1273
IBA
10/2021
1
Immunoglobulin M (IgM)
IBA
01/2021
1
ogalvibart
IBA
01/2021
1
Immunoglobulin A (IgA)
IBA
01/2021
1
crexavibart
IBA
01/2021
1
Prednisolone (Predate)
FDA Link
Generic
01/2021
1
Recombinant Proteins
IBA
10/2020
1
Biomarkers (Surrogate Marker)
IBA
10/2020
1
Proteome
IBA
10/2020
1
Antigen-Antibody Complex (Immune Complex)
IBA
01/2019
1
Anti-Retroviral Agents (Antiretroviral Agents)
IBA
11/2018
1
Bispecific Antibodies
IBA
01/2018
1
HLA-B57 antigen
IBA
01/2017
1
Anti-Bacterial Agents (Antibiotics)
IBA
04/2016
1
Indicators and Reagents (Reagents)
IBA
04/2015
1
Poly I-C
IBA
06/2014
1
Ligands
IBA
06/2014
1
Heparin-binding EGF-like Growth Factor (HB-EGF)
IBA
02/2014
1
Interleukin-23 (Interleukin 23)
IBA
09/2013
1
Interleukin-22 (IL-22)
IBA
09/2013
1
Alanine (L-Alanine)
FDA Link
06/2013
1
Immunoglobulin Isotypes
IBA
06/2013
1
flt3 ligand protein (flt3 ligand)
IBA
06/2013
Therapy/Procedure
12
Therapeutics
04/2022 - 08/2009
7
Immunotherapy
01/2022 - 10/2013
5
Art Therapy
04/2022 - 10/2013
1
Aftercare (After-Treatment)
01/2021
1
Injections
01/2019
1
Highly Active Antiretroviral Therapy (HAART)
11/2018